Upgrade to SI Premium - Free Trial

Vaxcyte, Inc. (PCVX) Misses Q4 EPS by 77c

February 27, 2024 5:27 PM

Vaxcyte, Inc. (NASDAQ: PCVX) reported Q4 EPS of ($1.82), $0.77 worse than the analyst estimate of ($1.05).

For earnings history and earnings-related data on Vaxcyte, Inc. (PCVX) click here.

Categories

Earnings